ACTRN12619001464156已完成4 期
atanoprost to alter optic nerve stress signals in eyes with optic disc drusen
Jesse Gale0 个研究点目标入组 23 人开始时间: 2019年10月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
Twenty three people with optic disc drusen participated. Latanoprost treatment was well tolerated, and lowered the eye pressure, but did not have a measurable effect on electrophysiology signals from the optic nerve cells.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 10 Years 至 o limit（—）
- 性别
- All
入选标准
- •Diagnosed and verifiable optic disc drusen
- •Willing and able to give consent (parental assent for those under 18)
- •Baseline intraocular pressure of 15 mmHg or higher in one eye
排除标准
- •Inability to attend testing schedule
- •Allergy to prostaglandin eye drops
- •Active eye disease requiring treatment, ocular surgery within 6 months
- •Pregnancy (or possible pregnancy during month of treatment)
研究者
相似试验
已完成
1 期
Effect of Latanoprost on Optic Nerve PerfusionTreatment OutcomeNCT06629129Zagazig University46
已完成
2 期
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGOpen-Angle GlaucomaOcular HypertensionNCT01037036Mati Therapeutics Inc.15
已完成
4 期
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.GlaucomaOcular HypertensionNCT00143208Pfizer's Upjohn has merged with Mylan to form Viatris Inc.250
已完成
不适用
Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomyPatients with open-angle glaucoma after trabeculectomyJPRN-UMIN000000893Kumamoto University60
Unknown
不适用
Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant GlaucomaPrimary GlaucomaOcular HypertensionNCT01361841Centre de recherche du Centre hospitalier universitaire de Sherbrooke141